Together Pharma Ltd (TGTR.TA)
ILA 421.9
(-1.29%)
ILA 421.9
(-1.29%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 27.61 Million ILS | 292.2% |
| 2022 | -14.36 Million ILS | -134.08% |
| 2021 | -6.13 Million ILS | -129.86% |
| 2020 | 20.55 Million ILS | 247.25% |
| 2019 | -13.95 Million ILS | -285.82% |
| 2018 | -3.61 Million ILS | -21382.35% |
| 2017 | 17 Thousand ILS | 100.56% |
| 2016 | -3.03 Million ILS | -9.28% |
| 2015 | -2.77 Million ILS | 55.27% |
| 2014 | -6.21 Million ILS | -32.38% |
| 2013 | -4.69 Million ILS | -12.09% |
| 2012 | -4.18 Million ILS | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 7.61 Million ILS | 22.84% |
| 2024 Q2 | 7.61 Million ILS | 0.0% |
| 2023 Q2 | 7.61 Million ILS | 0.0% |
| 2023 Q3 | 6.19 Million ILA | -18.63% |
| 2023 Q4 | 6.19 Million ILS | 0.0% |
| 2023 FY | - ILS | 292.2% |
| 2023 Q1 | 7.61 Million ILS | 622.15% |
| 2022 FY | - ILS | -134.08% |
| 2022 Q1 | -5.72 Million ILS | 52.74% |
| 2022 Q2 | -5.72 Million ILS | 0.0% |
| 2022 Q3 | -1.45 Million ILS | 74.54% |
| 2022 Q4 | -1.45 Million ILS | 0.0% |
| 2021 FY | - ILS | -129.86% |
| 2021 Q4 | -12.11 Million ILS | -1197.46% |
| 2021 Q3 | 1.1 Million ILS | -51.15% |
| 2021 Q2 | 2.26 Million ILS | -31.01% |
| 2021 Q1 | 3.27 Million ILS | 382.17% |
| 2020 Q3 | 8.52 Million ILS | -14.87% |
| 2020 Q2 | 10 Million ILS | 213.93% |
| 2020 FY | - ILS | 247.25% |
| 2020 Q1 | 3.18 Million ILS | 195.56% |
| 2020 Q4 | -1.16 Million ILS | -113.63% |
| 2019 Q1 | -3.64 Million ILS | -160.72% |
| 2019 Q4 | -3.33 Million ILS | 0.0% |
| 2019 FY | - ILS | -285.82% |
| 2019 Q2 | -3.64 Million ILS | 0.0% |
| 2019 Q3 | -3.33 Million ILS | 8.44% |
| 2018 Q4 | -1.39 Million ILS | 0.0% |
| 2018 Q1 | -411.5 Thousand ILS | -8330.0% |
| 2018 Q2 | -411.5 Thousand ILS | 0.0% |
| 2018 FY | - ILS | -21382.35% |
| 2018 Q3 | -1.39 Million ILS | -239.61% |
| 2017 Q2 | 3500.00 ILS | 0.0% |
| 2017 FY | - ILS | 100.56% |
| 2017 Q4 | 5000.00 ILS | 0.0% |
| 2017 Q3 | 5000.00 ILS | 42.86% |
| 2017 Q1 | 3500.00 ILS | 100.31% |
| 2016 Q4 | -1.12 Million ILS | -86.87% |
| 2016 Q2 | -829.47 Thousand ILS | 7.38% |
| 2016 Q3 | -603.57 Thousand ILS | 27.23% |
| 2016 Q1 | -895.57 Thousand ILS | -422.36% |
| 2016 FY | - ILS | -9.28% |
| 2015 FY | - ILS | 55.27% |
| 2015 Q2 | 422.66 Thousand ILS | 156.51% |
| 2015 Q1 | -747.88 Thousand ILS | 22.29% |
| 2015 Q3 | -211.73 Thousand ILS | -150.1% |
| 2015 Q4 | -171.44 Thousand ILS | 19.03% |
| 2014 Q3 | -1.73 Million ILS | 11.53% |
| 2014 Q1 | -1.13 Million ILS | 29.89% |
| 2014 FY | - ILS | -32.38% |
| 2014 Q4 | -962.38 Thousand ILS | 44.64% |
| 2014 Q2 | -1.96 Million ILS | -72.72% |
| 2013 Q2 | -945.34 Thousand ILS | 1.79% |
| 2013 FY | - ILS | -12.09% |
| 2013 Q3 | -1.27 Million ILS | -34.67% |
| 2013 Q4 | -1.62 Million ILS | -27.47% |
| 2013 Q1 | -962.62 Thousand ILS | -5.66% |
| 2012 Q4 | -911.02 Thousand ILS | 5.9% |
| 2012 FY | - ILS | 0.0% |
| 2012 Q3 | -968.16 Thousand ILS | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Cannabotech LTD | -14.81 Million ILA | 286.469% |